1. Prosonix Announce Agreement With Trimel Biopharma
(News/Latest)

... TriVairTM proprietary device technology is focused on the delivery of pharmaceutical compounds through pulmonary inhalation and nasal dispersion systems that utilize unique patent protected dosing technologies. ...

2. Prosonix Announce Agreement With Trimel Biopharma
(News/Newsflash)

... TriVairTM proprietary device technology is focused on the delivery of pharmaceutical compounds through pulmonary inhalation and nasal dispersion systems that utilize unique patent protected dosing technologies. ...

3. production of fine chemicals and pharmaceuticals
(Blog/blog)

... fine chemicals and pharmaceuticals?  ...

4. September 1-3, 2010: The Science of Medicines, Nottingham, UK
(events/events)

Prosonix CEO David Hipkiss will be presenting at the Academy of Pharmaceutical Sciences inaugural science conference UK-PharmSci 2010 entitled The Science of Medicines taking place 1-3 September 2010 at ...

5. Prosonix Announce The Launch Of UMAX technology
(News/Latest)

... in an exceptionally versatile manufacturing platform for a variety of Active Pharmaceutical Ingredients. Customer demand is now driving a rapid commercialization program aimed at the implementation of ...

6. Prosonix Announce The Launch Of UMAX technology
(News/Newsflash)

... in an exceptionally versatile manufacturing platform for a variety of Active Pharmaceutical Ingredients. Customer demand is now driving a rapid commercialization program aimed at the implementation of ...

7. UMAX Pharmaceutical Particle Engineering
(technology/Technology)

...  In all cases respiratory doses and fine particle fraction (FPF) can be improved significantly and often by over 100 % when compared with mechanically micronized material. Inhalable pharmaceutical materials ...

8. Product Pipeline - Making Better Medicines
(Pharmaceuticals/Pharmaceuticals)

Prosonix is developing a portfolio of engineered pharmaceutical mono and combination inhalation therapy products that offer distinct and high value advantages to patients.  With proven delivery across ...

9. Prosonix CEO David Hipkiss talks to CHEManager
(News/Latest)

... Medicines. Within this discussion David spoke at length about the application of proprietary pharmaceutical ultrasonic particle engineering technologies, ultrasonic process chemistry and processing equipment ...

10. Prosonix Wins Award at Major Conference- DDL-20
(News/Latest)

... area of pharmaceutical science. Given the fact that the poster sessions at DDL-20 were peer reviewed, this success once again emphasizes that Prosonix is now truly participating at ...

11. Prosonix Wins Poster Award at DDL-20
(News/Newsflash)

... area of pharmaceutical science. Given the fact that the poster sessions at DDL-20 were peer reviewed, this success once again emphasizes that Prosonix is now truly participating at the highest ...

12. Prosonix Attains International Quality Approval
(News/Latest)

... problems, to the licensing of its proprietary technology for the controlled production of advanced, highly engineered crystalline pharmaceutical materials.  The approval also underpins Prosonix progression ...

13. Medicines
(slider/slider)

Prosonix is the world leader in use of ultrasonic pharmaceutical particle engineering technologies for the manufacture of high value pharmaceutical powders and ultimately Making Better Medicines. Our pipeline ...

14. KTP Research Funding For Prosonix and Bath University
(News/Latest)

... to develop methodology and identify new processing technology for the manufacture of pharmaceutical co-crystals and binary API crystals suitable for use in inhaled and oral medicines.  The primary ...

15. Prosonix sponsor APS Inhalation 2009
(News/Latest)

Prosonix are delighted to be sponsoring the forthcoming Academy of Pharmaceutical Sciences (APS)Conference for Inhalation, 23-25 March 2009, at the University of Nottingham, UK, Over two days some of the ...

16. FDA Quality by Design
(Pharmaceuticals/Pharmaceuticals)

... (the ICH Q8 guidelines of 2004) the pharmaceutical industry to improved invention, development and commercialization of structured products using technologies that will result in superior product quality. ...

17. Ultrasonic Particle Rounding
(technology/Technology)

... technology represents an ideal solution to a range of common primary and secondary pharmaceutical manufacturing problems and also helps overcome many of the problems hitherto associated with classical ...

18. Pharmaceuticals
(Pharmaceuticals/Pharmaceuticals)

... and have the potential to transform inhalation and oral drug delivery. For further information on our pharmaceutical research and development please refer to: SAX | DISCUS | PRT |Sonocrystallization ...

19. Particle Engineering
(Pharmaceuticals/Pharmaceuticals)

Inhalation | Combination therapy |  SAX | DISCUS | PRT Controlling and actively manipulating nucleation and subsequent crystal growth behaviour is fundamental to the improvement of pharmaceutical crystallization ...

20. Sonocrystallization
(technology/Technology)

... be applied in secondary manufacture of pharmaceutical ingredients and lends itself to polymorphic systems. By controlling nucleation, we can take control of, and improve, crystal size distribution, morphology, ...